Evidence map›Paper›PMID 39937145›Full record

ArticleDiabetes technology & therapeutics2025

Correlation Between A1c and Continuous Glucose Monitor Time in Range in a Cohort of Pediatric Patients with Type 1 Diabetes.

Marisa Sobczak, Laura Pyle, Alexandra Sawyer, Gregory P Forlenza, G Todd Alonso

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marisa SobczakSchool of Medicine, University of Colorado, Aurora, Colorado, USA.
Laura PyleBarbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.
Alexandra SawyerDepartment of Pediatrics, University of Colorado, Aurora, Colorado, USA.
Gregory P ForlenzaBarbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.ORCID 0000-0003-3607-9788
G Todd AlonsoBarbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.ORCID 0000-0002-5676-761X

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Training Program in Diabetes ResearchT32DK063687 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Andrea Steck · 2002 to 2026
$5.2M
NIDDK NIH HHS P30 DK116073NIDDK NIH HHS T32 DK063687
6 · The paper itself

Abstract

Hemoglobin A1c (A1c) is the standard for glycemic control in type 1 diabetes. With recent increase in continuous glucose monitoring (CGM), other metrics (time in range 70-180 mg/dL [TIR]) are increasingly available. Data are limited for youth. We evaluated the association between A1c and time in range in a large pediatric cohort. We included patients from 2018 through 2020, aged <22 years with ≥70% CGM usage (

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycated HemoglobinAdolescentChildChild, PreschoolCohort StudiesFemaleGlycemic ControlHumansMaleTime FactorsYoung AdultBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humancontinuous glucose monitorhemoglobin A1cpediatricstime in rangetype 1 diabetes

Identifiers

PMID39937145
PMCPMC13107000

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.